Biography
Megan Carey is an epidemiologist and a PhD student in the Department of Medicine at the University of Cambridge. Her doctoral work will focus on the molecular epidemiology of Salmonella Typhi, with the aim of using genomic data to track the evolution and spread of antimicrobial resistance. She is also interested in the application of genomic data to inform public health policy, and the development and validation of low-cost infectious disease surveillance systems. She is the co-lead of a large-scale typhoid conjugate vaccine effectiveness study being conducted in the Democratic Republic of Congo as part of the Typhoid Conjugate Vaccine Introduction in Africa (THECA) program. Prior to matriculating at Cambridge, Megan was a Program Officer in the Global Health Program at the Bill and Melinda Gates Foundation, where she was responsible for the typhoid and cholera vaccine development and surveillance portfolios, as well as the Women Leaders in Global Health initiative. Megan received an M.S.P.H degree in Global Disease Epidemiology and Control at Johns Hopkins Bloomberg School of Public Health, as well as a certificate in Vaccine Science and Policy. Previously, Megan worked at the Engelberg Center for Health Care Reform at the Brookings Institute, and as a management consultant. She completed a post-baccalaureate premedical program at Georgetown University, and studied International Relations and Government as an undergraduate at Harvard College.
